Lomond Therapeutics Achieves FDA Clearance for Lonitoclax Trials Lomond Therapeutics has received FDA approval for its IND application for Lonitoclax, a promising treatment for acute myeloid leukemia with improved safety over existing therapies.

Lomond Therapeutics Achieves FDA Clearance for Lonitoclax Trials #USA #Dover #Lonitoclax #BCL2Inhibitor #LomondTherapeutics